Nitesh Ratnakar
Gastroenterology · Elkins, WVNPI 1285667410
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Pfizer at 39.2% of the total. 2025 is the largest year on record at $608, 3.1 times the $198 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in WV, where the typical reported total is $1,371.
Across 58 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$418
- AbbVie$336
- Johnson & Johnson$100
- Takeda Pharmaceuticals U.S.A., Inc.$51
- Madrigal Pharmaceuticals$26
- Ardelyx, Inc.$24
- plus $111 from 6 others
Across 4 payments — averaging $905.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shire North American Group Inc$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Adare Pharmaceuticals, Inc.$400
What the payments were for
- Food & beverage$1,067100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 24 | $418 |
| AbbVie(2 entities) | 15 | $336 |
| Johnson & Johnson | 6 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $51 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Ardelyx, Inc. | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| QOL Medical, LLC | 1 | $18 |
| Bristol Myers Squibb | 1 | $18 |
| Stryker | 1 | $18 |
| Echosens North America, Inc. | 1 | $13 |
How this compares
$1,067 in reported general payments places this provider in the 40th percentile of 72 gastroenterology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 196 | $2,774 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 131 | $2,260 |
| Omeprazole | 20 | $446 |
| Esomeprazole Magnesium | 18 | $348 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 15 | $296 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Elkins
- Jennifer VeverkaMorgantown$283K
- Shailendra SinghMorgantown$187K
- Mohamad HaffarSouth Charleston$118K
- Shyam ThakkarMorgantown$113K
- Hazem Al-AshhabParkersburg$93K
- Mark VoellingerWheeling$45K
- John NasrMorgantown$30K
- Wesam FrandahHuntington$28K
- Matthew KrafftMorgantown$28K
- Sardar Shah-KhanBeckley$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.